Fate Therapeutics, Inc. (FATE) Social Stream



Fate Therapeutics, Inc. (FATE): $55.01

3.24 (+6.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FATE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 474

in industry

Featured Post From StockTwits About FATE

@sava @inmb Let me get this straight, INMB market cap is $300mm they have great science, clear mechanism of action for their Alzheimer's Disease drug, their early results are fantastic, their advisor Dr. Tansey is mega resspected researcher and gave a Plenary session speech at AAIC, several catalysts ahead, and Phase 2 clinical trial starts in a few weeks?? Wow. perhaps other AD biotech investors might take a look. oh, and their NK cell therapy for cancer treatment, early phase I data is extremely encouraging. NK cell names like $IPSC and $FATE have $1.7B and $8B or so market caps, respectively. hmmm.... with $INMB we get the NK side for free, apparently. Long and strong.
OpenWater, published August 12, 2021

What Else are FATE Traders Talking About?


Other tickers frequently mentioned alongside FATE are IPSC and INMB.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5945 seconds.